Skip to main content
Erschienen in: Rheumatology International 9/2007

01.07.2007 | Original Article

P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters

verfasst von: Hayal Guler, Ergun Seyfeli, Gunsah Sahin, Mehmet Duru, Ferit Akgul, Hayrettin Saglam, Fatih Yalcin

Erschienen in: Rheumatology International | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Abstract

P wave dispersion (PWD) is a sign for the prediction of atrial fibrillation (AF). The aim of this study was to assess P wave dispersion and its relation with clinical and echocardiographic parameters in patients with rheumatoid arthritis (RA). Thirty RA patients (mean age 49 ± 10 years) and 27 healthy controls (mean age 47 ± 8 years) were included in the study. We performed electrocardiography and Doppler echocardiography on patients and controls. Maximum and minimum P wave duration were obtained from electrocardiographic measurements. PWD defined as the difference between maximum and minimum P wave duration was also calculated. Maximum P wave duration and PWD was higher in RA patients than controls (P = 0.031 and P = 0.001, respectively). However, there was no significant difference in minimum P wave duration between the two groups (P = 0.152). There was significant correlation between PWD and disease duration (r = 0.375, P = 0.009) and isovolumetric relaxation time (r = 0.390, P = 0.006). P wave duration and PWD was found to be higher in RA patients than healthy control subjects. PWD is closely associated with disease duration and left ventricular (LV) diastolic dysfunction.
Literatur
1.
Zurück zum Zitat Wallberg-Jonsson S, Öhman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 24:445–451PubMed Wallberg-Jonsson S, Öhman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 24:445–451PubMed
2.
Zurück zum Zitat Wislowska M, Sypula S, Kowalik I (1998) Echocardiographic findings, 24-hour electrocardiographic holter monitoring in patients with rheumatoid arthritis according to Steinbrocker’s criteria, functional index, value of Waaler–Rose titre and duration of disease. Clin Rheumatol 17:369–377CrossRefPubMed Wislowska M, Sypula S, Kowalik I (1998) Echocardiographic findings, 24-hour electrocardiographic holter monitoring in patients with rheumatoid arthritis according to Steinbrocker’s criteria, functional index, value of Waaler–Rose titre and duration of disease. Clin Rheumatol 17:369–377CrossRefPubMed
3.
Zurück zum Zitat Koopman WJ, Moreland LW (2005) Arthritis and allied conditions. A textbook of rheumatology, 15th edn. Lippincott Williams & Wilkins, Philadelphia Koopman WJ, Moreland LW (2005) Arthritis and allied conditions. A textbook of rheumatology, 15th edn. Lippincott Williams & Wilkins, Philadelphia
4.
Zurück zum Zitat Goldeli O, Dursun E, Komsuoglu B (1998) Dispersion of ventricular repolarisation: a new marker of ventricular arrhythmic in patients with rheumatoid arthritis. J Rheumatol 25:447–450PubMed Goldeli O, Dursun E, Komsuoglu B (1998) Dispersion of ventricular repolarisation: a new marker of ventricular arrhythmic in patients with rheumatoid arthritis. J Rheumatol 25:447–450PubMed
5.
Zurück zum Zitat Pırıldar T, Sekuri C, Utuk O, Tezcan UK (2003) QT dispersion in rheumatoid arthritis patients with and without Sjögren’s syndrome. Clin Rheumatol 22:225–228CrossRefPubMed Pırıldar T, Sekuri C, Utuk O, Tezcan UK (2003) QT dispersion in rheumatoid arthritis patients with and without Sjögren’s syndrome. Clin Rheumatol 22:225–228CrossRefPubMed
6.
Zurück zum Zitat Dilaveris PE, Gialafos EJ, Sideris S, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733–738CrossRefPubMed Dilaveris PE, Gialafos EJ, Sideris S, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733–738CrossRefPubMed
7.
Zurück zum Zitat Dilaveris PE, Gialofos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K, Gialafos JE (2000) Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 23:352–358CrossRefPubMed Dilaveris PE, Gialofos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K, Gialafos JE (2000) Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 23:352–358CrossRefPubMed
8.
Zurück zum Zitat Dilaveris PE, Gialafos JE (2001) P wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6:159–165CrossRefPubMed Dilaveris PE, Gialafos JE (2001) P wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6:159–165CrossRefPubMed
9.
Zurück zum Zitat Arnett FC, Edwothy SM, Bloch DA, Meshane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett FC, Edwothy SM, Bloch DA, Meshane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
10.
Zurück zum Zitat Steinbrocker O, Treger H, Cornelius H (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662 Steinbrocker O, Treger H, Cornelius H (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
11.
Zurück zum Zitat Van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850CrossRefPubMed Van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850CrossRefPubMed
12.
Zurück zum Zitat Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed
13.
Zurück zum Zitat Mutru O, Laakso M, İsomaki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77PubMed Mutru O, Laakso M, İsomaki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77PubMed
14.
Zurück zum Zitat Mody GM, Stevens JE, Meyers OL (1987) The heart in rheumatoid arthritis: a clinical and echocardiographic study. Q J Med 65:921–928PubMed Mody GM, Stevens JE, Meyers OL (1987) The heart in rheumatoid arthritis: a clinical and echocardiographic study. Q J Med 65:921–928PubMed
15.
Zurück zum Zitat Cindas A, Gokce-Kutsal Y, Tokgozoklu L, Karanfil A (2002) QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol 31:22–26CrossRefPubMed Cindas A, Gokce-Kutsal Y, Tokgozoklu L, Karanfil A (2002) QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol 31:22–26CrossRefPubMed
16.
Zurück zum Zitat Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJF (2003) Rheumatoid arthritis and macrovascular disease. Rheumatology 42:292–297CrossRefPubMed Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJF (2003) Rheumatoid arthritis and macrovascular disease. Rheumatology 42:292–297CrossRefPubMed
17.
Zurück zum Zitat Yildirir A, Aksoyek S, Calguneri M, Aytemir K, Kabakci G, Ovunç K, Nazlı F, Ozmen A, Oto A, Kes S (2000) QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatology 39:875–879CrossRefPubMed Yildirir A, Aksoyek S, Calguneri M, Aytemir K, Kabakci G, Ovunç K, Nazlı F, Ozmen A, Oto A, Kes S (2000) QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatology 39:875–879CrossRefPubMed
18.
Zurück zum Zitat Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ (1990) Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol 26:497–502CrossRef Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ (1990) Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol 26:497–502CrossRef
19.
Zurück zum Zitat Leier CV, Meacham JA, Schall SF (1978) Prolonged atrial conduction: a major predisposing factor to atrial flutter. Circulation 57:213–216PubMed Leier CV, Meacham JA, Schall SF (1978) Prolonged atrial conduction: a major predisposing factor to atrial flutter. Circulation 57:213–216PubMed
20.
Zurück zum Zitat Aytemir K, Ozer N, Atalar E, Sade E, Aksoyek S, Ovunç K, Oto A, Ozmen F, Kes S (2000) P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation . Pacing Clin Electrophysiol 23:1109–1112CrossRefPubMed Aytemir K, Ozer N, Atalar E, Sade E, Aksoyek S, Ovunç K, Oto A, Ozmen F, Kes S (2000) P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation . Pacing Clin Electrophysiol 23:1109–1112CrossRefPubMed
21.
Zurück zum Zitat Yilmaz R, Demirbag R (2005) P-wave dispersion in patients with stable coronary artery disease and its relationship with severity of the disease. J Electrocardiol 38(3):279–284CrossRefPubMed Yilmaz R, Demirbag R (2005) P-wave dispersion in patients with stable coronary artery disease and its relationship with severity of the disease. J Electrocardiol 38(3):279–284CrossRefPubMed
22.
Zurück zum Zitat Gunduz H, Binak E, Arinc H, Akdemir R, Ozhan H, Tamer A, Uyan C (2005) The relationship between P wave dispersion and diastolic dysfunction. Tex Heart Inst J 32:163–167PubMed Gunduz H, Binak E, Arinc H, Akdemir R, Ozhan H, Tamer A, Uyan C (2005) The relationship between P wave dispersion and diastolic dysfunction. Tex Heart Inst J 32:163–167PubMed
23.
Zurück zum Zitat Yilmaz R, Kasap H, Baykan M, Durmus I, Kaplan S, Celik S, Erdol C (2005) Assessment of left ventricular function by Doppler tissue imaging in patients with atrial fibrillation following acute myocardial infarction. Int J Cardiol 102:79–85CrossRefPubMed Yilmaz R, Kasap H, Baykan M, Durmus I, Kaplan S, Celik S, Erdol C (2005) Assessment of left ventricular function by Doppler tissue imaging in patients with atrial fibrillation following acute myocardial infarction. Int J Cardiol 102:79–85CrossRefPubMed
24.
Zurück zum Zitat Bonfiglio T, Atwater EC (1969) Heart disease in patients with seropositive rheumatoid arthritis. Arch Intern Med 124:714–719CrossRefPubMed Bonfiglio T, Atwater EC (1969) Heart disease in patients with seropositive rheumatoid arthritis. Arch Intern Med 124:714–719CrossRefPubMed
25.
Zurück zum Zitat Reimer KA, Rodgers RF, Oyasu R (1976) Rheumatoid arthritis with rheumatoid heart disease and granulomatous aortitis. JAMA 235:2510–2512CrossRefPubMed Reimer KA, Rodgers RF, Oyasu R (1976) Rheumatoid arthritis with rheumatoid heart disease and granulomatous aortitis. JAMA 235:2510–2512CrossRefPubMed
26.
27.
Zurück zum Zitat Iglesias Cubero G, Rodriguez Reguero JJ, Rojo Ortega JM (1993) Restrictive cardiomyopathy caused by chloroquine. Br Heart J 69:451–452PubMed Iglesias Cubero G, Rodriguez Reguero JJ, Rojo Ortega JM (1993) Restrictive cardiomyopathy caused by chloroquine. Br Heart J 69:451–452PubMed
28.
Zurück zum Zitat Ratliff NB, Estes ML, Myles JL, Shirey EK, McMahon JT (1987) Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. N Engl J Med 316:191–193PubMedCrossRef Ratliff NB, Estes ML, Myles JL, Shirey EK, McMahon JT (1987) Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. N Engl J Med 316:191–193PubMedCrossRef
29.
Zurück zum Zitat Qasim FJ, Thiru S, Gillespie K (1997) Gold and D-penicillamine induce vasculitis and up-regulate m RBA for IL-4 in the Brown Norway rat: support for a role of Th2 cell activity. Clin Exp Immunol 108:438–445CrossRefPubMed Qasim FJ, Thiru S, Gillespie K (1997) Gold and D-penicillamine induce vasculitis and up-regulate m RBA for IL-4 in the Brown Norway rat: support for a role of Th2 cell activity. Clin Exp Immunol 108:438–445CrossRefPubMed
30.
Zurück zum Zitat Page J, Henry D (2000) Consumption of NSAIDs and the development of congestive heart failure in elderly patients. Arch Intern Med 160:777–784CrossRefPubMed Page J, Henry D (2000) Consumption of NSAIDs and the development of congestive heart failure in elderly patients. Arch Intern Med 160:777–784CrossRefPubMed
31.
Zurück zum Zitat Nashel D (1986) Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 80:925–929CrossRefPubMed Nashel D (1986) Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 80:925–929CrossRefPubMed
32.
Zurück zum Zitat Landewe R, van den Borne B, Breedveld F, et al. (2000) Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 355:1616–1617CrossRefPubMed Landewe R, van den Borne B, Breedveld F, et al. (2000) Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 355:1616–1617CrossRefPubMed
33.
Zurück zum Zitat Haagsma C, Blom H, van Riel PL, et al. (1999) Influence of sulfasalazine, methotrexate and combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79–84PubMedCrossRef Haagsma C, Blom H, van Riel PL, et al. (1999) Influence of sulfasalazine, methotrexate and combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79–84PubMedCrossRef
34.
Zurück zum Zitat Schiff MH, Strand V, Oed C, Loew-Frriedrich I (2000) Leflunomide: efficacy and safety in clinical trials for the treatment of rheumatoid arthritis. Drugs Today Barc 36:383–394PubMed Schiff MH, Strand V, Oed C, Loew-Frriedrich I (2000) Leflunomide: efficacy and safety in clinical trials for the treatment of rheumatoid arthritis. Drugs Today Barc 36:383–394PubMed
35.
Zurück zum Zitat Tukek T, Akkaya V, Demirel S, Sozen AB, Kudat H, Atılgan D, Ozcan M, Guven O, Korkut F (2000) Effect of valsalva maneuver on surface electrocardiographic P wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol 85:896–899CrossRefPubMed Tukek T, Akkaya V, Demirel S, Sozen AB, Kudat H, Atılgan D, Ozcan M, Guven O, Korkut F (2000) Effect of valsalva maneuver on surface electrocardiographic P wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol 85:896–899CrossRefPubMed
36.
Zurück zum Zitat Evrengul H, Dursunoglu D, Cobankara N, Polat B, Seleci D, Kabukcu S, Kaftan A (2004) Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 24:198–202CrossRefPubMed Evrengul H, Dursunoglu D, Cobankara N, Polat B, Seleci D, Kabukcu S, Kaftan A (2004) Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 24:198–202CrossRefPubMed
37.
Zurück zum Zitat Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63–70PubMed Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63–70PubMed
Metadaten
Titel
P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters
verfasst von
Hayal Guler
Ergun Seyfeli
Gunsah Sahin
Mehmet Duru
Ferit Akgul
Hayrettin Saglam
Fatih Yalcin
Publikationsdatum
01.07.2007
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 9/2007
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0307-8

Weitere Artikel der Ausgabe 9/2007

Rheumatology International 9/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.